Biotechnology VALUE FUND II L.P., Insider at LIGAND PHARMACEUTICALS INC (LGND), bought 37,871 shares at $11.93 ($451K) on 2011-08-19, disclosed to the SEC on 2011-08-22.
Open-market purchase of $451k LGND by Insider. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.91 | 871 | $10K | 2.3% |
| 2 | $11.91 | 15,700 | $187K | 41.4% |
| 3 | $11.93 | 400 | $5K | 1.1% |
| 4 | $11.93 | 1,900 | $23K | 5.0% |
| 5 | $11.93 | 19,000 | $227K | 50.2% |
| Total | $11.92 avg | 37,871 |
| $451K |
| 100% |
| Filing → |
| THRD | BUY | 2022-12-22 | $1.7M | — | Filing → |
| KYMR | BUY | 2022-08-23 | $14.2M | — | Filing → |
| RPTX | BUY | 2022-06-15 | $3.8M | — | Filing → |